Related Experiment Videos
Inflammation in end-stage renal failure: could it be treated?
1Division of Nephrology, Department of Medicine, University of California, Davis, and Department of Veterans Affairs Medical Center, Mather, CA, USA.
Summary
Chronic inflammation contributes to malnutrition and cardiovascular disease (CVD) in end-stage renal disease (ESRD) patients. Targeting this inflammation may improve survival for those with ESRD.
Area of Science:
- Nephrology
- Cardiology
- Immunology
Background:
- End-stage renal disease (ESRD) is linked to high mortality, primarily from cardiovascular disease (CVD).
- Traditional risk factors inadequately explain the high CVD prevalence in ESRD.
- Chronic inflammation is a key non-traditional risk factor in ESRD, contributing to malnutrition and atherosclerosis.
Purpose of the Study:
- To investigate the role of chronic inflammation in the development of malnutrition and CVD in ESRD.
- To explore the potential benefits of suppressing the malnutrition-inflammation-atherosclerosis (MIA) cycle.
- To examine the associations between inflammation, oxidative stress, and endothelial dysfunction in ESRD.
Main Methods:
- Review of recent evidence on inflammation, malnutrition, and CVD in ESRD.
- Analysis of pathogenetic mechanisms linking inflammation to vascular injury and malnutrition.
- Exploration of the interplay between inflammation, oxidative stress, and endothelial dysfunction.
Main Results:
- Pro-inflammatory cytokines are central to malnutrition and CVD in ESRD.
- Inflammation is strongly associated with increased oxidative stress and endothelial dysfunction.
- The MIA cycle is a significant concern for dialysis patients.
Conclusions:
- Suppression of the MIA cycle may enhance survival in dialysis patients.
- Further research into anti-inflammatory treatments is warranted to improve outcomes in ESRD.
- Targeting chronic inflammation could mitigate malnutrition and cardiovascular complications in ESRD.